BrightGene Bio (China) Volatility
| 688166 Stock | 29.55 0.68 2.36% |
At this point, BrightGene Bio is not too volatile. BrightGene Bio Medical secures Sharpe Ratio (or Efficiency) of 0.0141, which signifies that the company had a 0.0141% return per unit of risk over the last 3 months. We have found twenty-two technical indicators for BrightGene Bio Medical, which you can use to evaluate the volatility of the firm. Please confirm BrightGene Bio's Mean Deviation of 2.6, risk adjusted performance of (0.01), and Standard Deviation of 3.74 to double-check if the risk estimate we provide is consistent with the expected return of 0.0525%. Key indicators related to BrightGene Bio's volatility include:
510 Days Market Risk | Chance Of Distress | 510 Days Economic Sensitivity |
BrightGene Bio Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of BrightGene daily returns, and it is calculated using variance and standard deviation. We also use BrightGene's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of BrightGene Bio volatility.
BrightGene |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as BrightGene Bio can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of BrightGene Bio at lower prices to lower their average cost per share. Similarly, when the prices of BrightGene Bio's stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
BrightGene Bio Market Sensitivity And Downside Risk
BrightGene Bio's beta coefficient measures the volatility of BrightGene stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents BrightGene stock's returns against your selected market. In other words, BrightGene Bio's beta of 0.34 provides an investor with an approximation of how much risk BrightGene Bio stock can potentially add to one of your existing portfolios. BrightGene Bio Medical exhibits very low volatility with skewness of 1.42 and kurtosis of 4.74. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure BrightGene Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact BrightGene Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze BrightGene Bio Medical Demand TrendCheck current 90 days BrightGene Bio correlation with market (Dow Jones Industrial)BrightGene Beta |
BrightGene standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 3.73 |
It is essential to understand the difference between upside risk (as represented by BrightGene Bio's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of BrightGene Bio's daily returns or price. Since the actual investment returns on holding a position in brightgene stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in BrightGene Bio.
BrightGene Bio Medical Stock Volatility Analysis
Volatility refers to the frequency at which BrightGene Bio stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with BrightGene Bio's price changes. Investors will then calculate the volatility of BrightGene Bio's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of BrightGene Bio's volatility:
Historical Volatility
This type of stock volatility measures BrightGene Bio's fluctuations based on previous trends. It's commonly used to predict BrightGene Bio's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for BrightGene Bio's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on BrightGene Bio's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. BrightGene Bio Medical Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
BrightGene Bio Projected Return Density Against Market
Assuming the 90 days trading horizon BrightGene Bio has a beta of 0.3424 . This suggests as returns on the market go up, BrightGene Bio average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding BrightGene Bio Medical will be expected to be much smaller as well.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to BrightGene Bio or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that BrightGene Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a BrightGene stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
BrightGene Bio Medical has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives a BrightGene Bio Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.BrightGene Bio Stock Risk Measures
Assuming the 90 days trading horizon the coefficient of variation of BrightGene Bio is 7105.4. The daily returns are distributed with a variance of 13.94 and standard deviation of 3.73. The mean deviation of BrightGene Bio Medical is currently at 2.57. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.82
α | Alpha over Dow Jones | -0.09 | |
β | Beta against Dow Jones | 0.34 | |
σ | Overall volatility | 3.73 | |
Ir | Information ratio | -0.02 |
BrightGene Bio Stock Return Volatility
BrightGene Bio historical daily return volatility represents how much of BrightGene Bio stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company accepts 3.7331% volatility on return distribution over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.8215% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About BrightGene Bio Volatility
Volatility is a rate at which the price of BrightGene Bio or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of BrightGene Bio may increase or decrease. In other words, similar to BrightGene's beta indicator, it measures the risk of BrightGene Bio and helps estimate the fluctuations that may happen in a short period of time. So if prices of BrightGene Bio fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.3 ways to utilize BrightGene Bio's volatility to invest better
Higher BrightGene Bio's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of BrightGene Bio Medical stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. BrightGene Bio Medical stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of BrightGene Bio Medical investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in BrightGene Bio's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of BrightGene Bio's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
BrightGene Bio Investment Opportunity
BrightGene Bio Medical has a volatility of 3.73 and is 4.55 times more volatile than Dow Jones Industrial. 33 percent of all equities and portfolios are less risky than BrightGene Bio. You can use BrightGene Bio Medical to enhance the returns of your portfolios. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of BrightGene Bio to be traded at 35.46 in 90 days.Significant diversification
The correlation between BrightGene Bio Medical and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding BrightGene Bio Medical and DJI in the same portfolio, assuming nothing else is changed.
BrightGene Bio Additional Risk Indicators
The analysis of BrightGene Bio's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in BrightGene Bio's investment and either accepting that risk or mitigating it. Along with some common measures of BrightGene Bio stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.27) | |||
| Mean Deviation | 2.6 | |||
| Coefficient Of Variation | (4,313) | |||
| Standard Deviation | 3.74 | |||
| Variance | 13.98 | |||
| Information Ratio | (0.02) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
BrightGene Bio Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against BrightGene Bio as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. BrightGene Bio's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, BrightGene Bio's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to BrightGene Bio Medical.
Complementary Tools for BrightGene Stock analysis
When running BrightGene Bio's price analysis, check to measure BrightGene Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrightGene Bio is operating at the current time. Most of BrightGene Bio's value examination focuses on studying past and present price action to predict the probability of BrightGene Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrightGene Bio's price. Additionally, you may evaluate how the addition of BrightGene Bio to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |